deaf
Clinically, hearing impairment is divided into two categories: conductive hearing loss and neurological (sensory) hearing loss. Conductive hearing loss refers to hearing loss caused by damage to the "tympanic membrane-ossicular chain" system from the external auditory canal to the middle ear; neurological hearing loss belongs to sensorineural lesions, which refers to damage to the nerve conduction pathway from the cochlea or auditory nerve in the inner ear to the auditory center, resulting in hearing loss or disappearance, also known as sensorineural hearing loss. In the former, sound waves can also be transmitted to the inner ear through bone conduction from the skull to cause sensation, while in the latter, hearing is weakened or lost due to nerve damage. Tinnitus is the conscious hearing of a sound in the ear, which is an irritating lesion of the cochlear nerve trunk or nerve endings. Currently, most scholars also advocate that it should be classified as a hearing impairment.
-
Site of disease:
Ear
-
Infectious :
Not contagious
-
Frequent population:
All populations, mostly middle-aged and elderly people
-
Related symptoms:
Neurological deafness
Central deafness
Conductive deafness
Cochlear deafness
-
Concurrent disease:
Related Drugs
Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal artery occlusion, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; 4. Ocular circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Sanbao Capsule
Manufacturer:
Heilongjiang Bifujin North Pharmaceutical Co., Ltd.
Puerarin Glucose Injection
Indication: It can be used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, sudden deafness and ischemic cerebrovascular disease, viral myocarditis in children, diabetes, etc.
Manufacturer:
Jiangsu Huai'an Shuanghe Pharmaceutical Co., Ltd.
Puerarin Glucose Injection
Indication: It can be used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, sudden deafness and ischemic cerebrovascular disease, viral myocarditis in children, diabetes, etc.
Puerarin Glucose Injection
Indication: It can be used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, sudden deafness and ischemic cerebrovascular disease, viral myocarditis in children, diabetes, etc.